Current Treatment Status Brain metastasis has emerged as one of the most significant therapeutic challenges in the management of human epidermal growth factor receptor 2 (HER2)-positive breast cancer, occurring in approximately 30–50% of patients with advanced disease.1 It is associated with poor prognosis, significant morbidity, and diminished quality of life, as metastatic lesions in the central nervous system (CNS) often lead to debilitating neurological symptoms such as headaches,...